With the rise in anti-coronavirus vaccinations, numbers of Covid-19 cases have significantly dropped in Germany and elsewhere. But protective masks are almost certainly to stay in great demand – both because of state rules and personal preferences.
Rare but serious cases of blood clotting in people inoculated by the vector vaccines produced by AstraZeneca and Johnson&Johnson have been one obstacle to the international immunization campaigns against Covid-19.
Jörn Holtmeier, managing director of the Association of the German Trade Fair Industry (AUMA), discusses how the sector is coping with coronavirus restrictions.
As cases of Covid-19 surged again across the world last fall, German authorities took quick action to limit infection numbers. The measures were typical of Germany’s response to the unprecedented situation: attempting to balance economic concerns with necessary and timely health interventions.
How one British-German designer’s problem-solving acuity opened the door to Europe for selling Covid-adapted backpacks
How a venerable German company used the government’s furlough program to maintain production and retain its workforce
How a family-run carpentry shop in Braunschweig – which exceeded its 2019 turnover in November 2020 – stayed solvent and got through the worst of the economic disruption
How Swiss pharma group Roche is accelerating antibody and antigen testing for Covid-19 by investing heavily in its German facilities
How Pfizer’s coronavirus vaccine breakthrough was achieved together with a previously obscure Mainz-based firm, BioNTech, which is now worth over a billion euros
How an international green energy company is pushing ahead with expansion into Germany and starting production of hydrogen electrolyzers
